- BNF:
- immune system/malignant disease
- Status:
- Red
- Decision Date:
- January 2018
Comments
RED:
- NICE TA616: for treating relapsing-remitting multiple sclerosis. (Replaces NICE TA493). (Decision date - February 2020).
NHS England drug. To be used in line with NHS England commissioning intentions.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again